Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

176 results
Display

Effect of immune-mediated vascular injury on the coagulation- regulatory mechanism of the human endothelial cells; changes of tissue-type plasminogen activator, plasminogen activator inhibitor- 1 and von Willebrand factor

Park S, Song YW

  • KMID: 1773319
  • Korean J Intern Med.
  • 1991 Feb;40(2):205-213.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of the dosing regimen of tissue-type plasminogen activator on blood coagulation system in experimental pulmonary embolism

Chung HS, Kim HJ, Shim YS

  • KMID: 1699942
  • Tuberc Respir Dis.
  • 1993 Oct;40(5):474-482.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Intravitreal Tissue Plasminogen Activator and Gas Injection in Submacular Hemorrhage

Kim IK, Hahn DK

  • KMID: 2108294
  • J Korean Ophthalmol Soc.
  • 1997 Oct;38(10):1870-1874.
Tissue plasminogen activator(tPA) has been used as useful adjunct in the submacular hemorrhage due to age-related macular degeneration, which was injected and able to dissolve clotted blood. It was also...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Tissue Plasminogen Activator for Treatment of Subretinal Hemorrhage

Kwak NH, Yoo JS, Huh W

  • KMID: 2205171
  • J Korean Ophthalmol Soc.
  • 1995 Dec;36(12):2138-2141.
We report removing a large subretinal hemorrhage by means of vitrectomy combined with the use of tissue plasminogen activator(tPA) to facilitate clot removal. A 25-year-old man had a 4 days...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The treatment of the pulmonary embolism with tissue plasminogen activator: A case report

Jung MG, Lee HK

Pulmonary embolism can occur in various situations and it can result in severe hemodynamic instability, including cardiac arrest. Because of its fatality, diagnosis and treatment should be immediate and proper....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Ischemic Stroke Caused by a Hyaluronic Acid Gel Embolism Treated with Tissue Plasminogen Activator

Lee S, Jung JH, Seo J, Kim EG

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Effect of Tissue Plasminogen Activator in Vitreous Hemorrhage

Im YW, Moon JI, Jung SM

  • KMID: 2123162
  • J Korean Ophthalmol Soc.
  • 1993 Nov;34(11):1135-1140.
There has been several reports that tissue plasminogen activator(tPA) accelerated the fibrinolysis in vitreous cavity in-vivo. We investigated the efficacy of intravitreal tPA injection(25 microgram/100 microgram, 0.1 ml) for treatment...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Tissue Plasminogen Activator in Choronic Subdural Hematoma & Its Relationship with CT Findings

Chung YG, Kim HK, Park YK, Kim BR, Chung HS, Lee HK, Lee KC, Chu JW

  • KMID: 2068012
  • J Korean Neurosurg Soc.
  • 1994 Jan;23(1):35-40.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Femoral Artery Thrombosis Following Cardiac Cathetherization Treated with Recombinant Tissue Plasminogen Activator in Neonate

Han JJ, Ko HK, Yoo Y, Jang GY, Son CS, Lee JW, Kang CH

  • KMID: 1852895
  • J Korean Pediatr Cardiol Soc.
  • 2006 Sep;10(3):334-338.
Femoral artery thrombosis is an uncommon but potentially serious complication following pediatric cardiac catheterization. Treatment options of thrombosis include intravenous heparin infusion, thrombolytic therapy such as streptokinase, urokinase and tissue...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Surgical Removal of Macular Subretinal Hemorrhage

Kim NS, Yun YD, Kwon OW

  • KMID: 2123476
  • J Korean Ophthalmol Soc.
  • 1996 Jul;37(7):1149-1153.
Subretinal hemorrhage affecting the macula may occur secondary to a variety of etiologies and often results in significant visual loss. Recently, we removed five subretinal hemorrhage affecting the macula by...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment of Total Hyphema Following Trauma and Surgery with Tissue Plasminogen Activator

Chung SM, Koo TH, Kim MH, Kim SM

  • KMID: 2108210
  • J Korean Ophthalmol Soc.
  • 1997 Apr;38(4):692-697.
Delayed clearing from the total hyphema resulting from ocular trauma and surgery causes intractable glaucoma and corneal staining by blood-pigments such as hemoglobin and small amounts of hemosiderin. The management...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of Tissue Plasminogen Activator on Premacular Hemorrhage

Chung J, Kim MH, Chang KY, Chung SM

  • KMID: 2147621
  • J Korean Ophthalmol Soc.
  • 1999 May;40(5):1253-1259.
Early vitrectomy is recommended for eyes with premacular hemorrhage, which facilitates fibrovascular proliferation and macular traction. To assess the effect of tissue plasminogen activator(tPA)on the absorption of premacular hemorrhage, we...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Successful thrombolytic therapy with recombinant tissue-type plasminogen activator for massive pulmonary embolism: A case report

Kim MS, Kim KM, Woo SH, Lim YH, Yon JH, Jeon SG

Massive pulmonary embolism is associated with significant perioperative morbidity and mortality. We report here on a case of a 69-year-old man who suffered a massive pulmonary embolism with pulseless electrical...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment of experimental vitreous hemorrhage with tissue plasminogen activator

Min WK, Kim YB, Lee KM

Tissue plasminogen activator(tPA) is a fibrin-specific fibrinolytic agent that has recently been shown to be effective in accelerating the clearance of hyphema. Intravitreal injection of tPA can promote rapid lysis...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment of Acute Ischemic Stroke: Thrombolysis

Kwon SU

  • KMID: 2143872
  • Korean J Cerebrovasc Dis.
  • 2001 Sep;3(2):113-118.
Many case series showed local intraarterial thrombolysis using urokinase was effective treatment for acute ischemic stroke, but it was performed in the limited area because its outcome largely depends upon...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Recent advances in ischemic stroke management

Yoon CW, Rha JH

There have been recent advances in the hyperacute treatment and secondary prevention of ischemic stroke. Thrombolysis with intravenous tissue plasminogen activator has been approved for a 3 to 4.5 hour...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical significance of plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in chronic stable angina

Choi YJ, Park SS, Park SW, Sohn DW, Oh BH, Lee MM, Park YB, Choi YS, Seo JD, Lee YW

BACKGROUND: Impaired fibrinolytic system has been considered to play an important role in the pathogenesis of coronary artery disease, especially associated with thrombus formation. To evaluate the pathogenetic role of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effects of Tissue Plasminogen Activator in Experimental Hyphema of White Rabbits

Chung SM, Baek NH, Rhee SW

  • KMID: 2205008
  • J Korean Ophthalmol Soc.
  • 1992 Dec;33(12):1142-1153.
The purpose of this study is to observe the resorption effect of the anterior chamber blood by introducing tissue plasminogen activator (tPA). The results were as follows: 1. Hyphema of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Thrombolytic Therapy for Repeated Prosthetic Valvular Thrombosis That's Associated with Pregnancy under Heparin Anticoagulation

Choe JW, Kim YI

  • KMID: 1485556
  • Korean J Thorac Cardiovasc Surg.
  • 2008 Aug;41(4):484-488.
During long-term anticoagulation treatment with using heparin in a pregnant patient with a mechanical mitral prosthesis, we observed several anticoagulation-related complications, including repeated prosthetic valve thrombosis. This was found to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of Recombinant Tissue Plasminogen Activator on the Intracerebral Hematomas in Experimental Cat Models

Jo KW, Kim SR, You SH, Kim SD, Park IS, Baik MW

  • KMID: 1956357
  • J Korean Neurosurg Soc.
  • 2005 Apr;37(4):287-292.
OBJECTIVE: Recent clinical studies have demonstrated that intracisternal administration of recombinant tissue plasminogen activator(rt-PA) can facilitate the normal clearing of blood from the subarachnoid space. Urokinase, a first generation fibrinolytic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr